PATRUNO, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 852
AS - Asia 492
EU - Europa 424
SA - Sud America 123
Continente sconosciuto - Info sul continente non disponibili 82
AF - Africa 26
OC - Oceania 3
Totale 2.002
Nazione #
US - Stati Uniti d'America 807
SG - Singapore 204
IT - Italia 157
BR - Brasile 96
CN - Cina 87
HK - Hong Kong 69
DE - Germania 55
VN - Vietnam 47
FR - Francia 41
RU - Federazione Russa 40
SE - Svezia 37
GB - Regno Unito 24
BD - Bangladesh 23
FI - Finlandia 22
CA - Canada 20
MX - Messico 18
IN - India 17
PL - Polonia 11
ES - Italia 10
AR - Argentina 9
IQ - Iraq 8
ID - Indonesia 6
LT - Lituania 6
TR - Turchia 6
CO - Colombia 5
JP - Giappone 5
ZA - Sudafrica 5
AT - Austria 4
DZ - Algeria 4
SA - Arabia Saudita 4
TN - Tunisia 4
VE - Venezuela 4
AU - Australia 3
CR - Costa Rica 3
EC - Ecuador 3
EG - Egitto 3
PK - Pakistan 3
RO - Romania 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GT - Guatemala 2
KE - Kenya 2
MY - Malesia 2
NL - Olanda 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AM - Armenia 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
GF - Guiana Francese 1
GH - Ghana 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LY - Libia 1
MA - Marocco 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
RE - Reunion 1
UY - Uruguay 1
Totale 1.920
Città #
Ashburn 119
Singapore 92
San Jose 88
Milan 76
Hong Kong 68
Dallas 36
Chandler 34
Council Bluffs 32
Beijing 31
Los Angeles 29
Nyköping 26
Munich 24
New York 22
Lauterbourg 21
Helsinki 16
Rome 16
Santa Clara 15
Columbus 13
Fairfield 13
Falkenstein 13
Orem 13
Buffalo 12
Hanoi 12
Phoenix 12
Seattle 12
Chicago 11
Boardman 10
Denver 10
Frankfurt am Main 10
Ho Chi Minh City 10
Houston 10
Mexico City 10
São Paulo 10
Figino 9
Montreal 8
Wilmington 8
Woodbridge 8
Brooklyn 7
Lawrence 7
Turin 7
Warsaw 7
Cambridge 6
Chennai 6
Roxbury 6
Turku 6
Ankara 5
Atlanta 5
Bari 5
Inglewood 5
London 5
Miami 5
Pescara 5
Johannesburg 4
San Francisco 4
Thái Nguyên 4
Tokyo 4
Xi'an 4
Baghdad 3
Campi Salentina 3
Des Moines 3
East Gwillimbury 3
Elk Grove Village 3
Haiphong 3
Hyderabad 3
Reston 3
Salt Lake City 3
San Diego 3
San José 3
The Bronx 3
Wroclaw 3
Abidjan 2
Addis Ababa 2
Algiers 2
Ann Arbor 2
Belgrade 2
Biên Hòa 2
Brasília 2
Buckeye 2
Caracas 2
Chesapeake 2
Concord 2
Da Nang 2
Dhaka 2
Fortaleza 2
Fulham 2
Hải Dương 2
Jakarta 2
Kolodenka 2
Kuala Lumpur 2
Lima 2
Limeira 2
Manchester 2
Maricá 2
Medellín 2
Minneapolis 2
Mumbai 2
Nairobi 2
Najaf 2
Naples 2
Neuilly-sur-Seine 2
Totale 1.165
Nome #
Use of Dupilumab for 543 Adult Patients with Moderate-To-Severe Atopic Dermatitis: A Multicenter, Retrospective Study 155
Myroxylon pereirae (balsam of Peru): Still worth testing? 121
Patch testing with textile dye mix in Italy: A 2-year multicenter SIDAPA study 118
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response 110
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018–2019 109
Skin tests in the diagnosis of adverse drug reactions 108
Urticaria: Recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology 107
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study 99
Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients 93
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis 92
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens 87
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History 84
Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis 77
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study–il AD (Italian landscape atopic dermatitis) 75
Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis: An Italian multicentre study 73
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients 71
Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study 65
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study 64
Safety of omalizumab in chronic urticaria during pregnancy: a real-life study 62
Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: A multicenter case series study 62
AtopyReg®: the prospective Italian patient registry for moderate to severe atopic dermatitis in adults by SIDeMaST 59
Frequency of contact allergy to pentylene glycol. Retrospective cross-sectional study with data from the Società Italiana di Dermatologia Allergologica Professionale e Ambientale (SIDAPA) 56
Contact allergy to hydroxyisohexyl 3-cyclohexene carboxaldehyde in Italy: Prevalence, trend, and concordance with fragrance mix II 55
Totale 2.002
Categoria #
all - tutte 7.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202259 0 0 10 2 3 12 0 2 6 5 9 10
2022/202383 9 21 8 3 3 11 2 13 9 1 2 1
2023/202435 3 8 3 3 6 5 0 3 0 1 1 2
2024/2025330 8 0 6 5 9 27 25 36 10 10 70 124
2025/20261.312 172 76 59 206 166 65 100 35 174 87 34 138
2026/2027127 58 45 24 0 0 0 0 0 0 0 0 0
Totale 2.002